应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06667 美因基因
休市中 10-09 15:59:27
7.150
-0.025
-0.35%
最高
7.250
最低
7.120
成交量
19.06万
今开
7.250
昨收
7.175
日振幅
1.81%
总市值
15.80亿
流通市值
15.80亿
总股本
2.21亿
成交额
136.81万
换手率
0.09%
流通股本
2.21亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
美因基因10月9日回购15.2万股,耗资约109.25万港元
公告速递 · 10-09 17:36
美因基因10月9日回购15.2万股,耗资约109.25万港元
美因基因(06667)10月9日斥资109.25万港元回购15.2万股
智通财经 · 10-09 17:33
美因基因(06667)10月9日斥资109.25万港元回购15.2万股
美因基因:10月8日回购14.88万股,涉资约106.91万港元
公告速递 · 10-08 21:45
美因基因:10月8日回购14.88万股,涉资约106.91万港元
美因基因(06667.HK)10月7日耗资116.94万港元回购16.14万股
中金财经 · 10-07 22:17
美因基因(06667.HK)10月7日耗资116.94万港元回购16.14万股
美因基因回购16.14万股股份,总额约116.94万港元
公告速递 · 10-07 21:51
美因基因回购16.14万股股份,总额约116.94万港元
美因基因10月6日回购15.68万股,耗资约113.81万港元
公告速递 · 10-06
美因基因10月6日回购15.68万股,耗资约113.81万港元
美因基因(06667.HK)10月6日斥资113.81万港元回购15.68万股
智通财经 · 10-06
美因基因(06667.HK)10月6日斥资113.81万港元回购15.68万股
美因基因(06667)10月6日斥资113.81万港元回购15.68万股
智通财经 · 10-06
美因基因(06667)10月6日斥资113.81万港元回购15.68万股
美因基因更新2026年9月股份变动月报表,股本维持稳定
公告速递 · 10-05
美因基因更新2026年9月股份变动月报表,股本维持稳定
美因基因(06667)10月5日斥资56.74万港元回购8.06万股
智通财经 · 10-05
美因基因(06667)10月5日斥资56.74万港元回购8.06万股
美因基因10月5日回购80,600股股份,耗资约56.74万港元
公告速递 · 10-05
美因基因10月5日回购80,600股股份,耗资约56.74万港元
美因基因:10月2日斥资54.4万港元回购7.68万股
南方财经网 · 10-02
美因基因:10月2日斥资54.4万港元回购7.68万股
美因基因回购7.68万股股份,涉资约54.40万港元
公告速递 · 10-02
美因基因回购7.68万股股份,涉资约54.40万港元
美因基因回购9.48万股股份,总额约68.25万港元
公告速递 · 09-30
美因基因回购9.48万股股份,总额约68.25万港元
美因基因(06667)9月30日斥资68.25万港元回购9.48万股
智通财经 · 09-30
美因基因(06667)9月30日斥资68.25万港元回购9.48万股
美因基因回购9.2万股股份,耗资约65.62万港元
公告速递 · 09-29
美因基因回购9.2万股股份,耗资约65.62万港元
美因基因回购9.16万股股份,耗资约65.60万港元
公告速递 · 09-28
美因基因回购9.16万股股份,耗资约65.60万港元
美因基因(06667)9月28日斥资65.6万港元回购9.16万股
智通财经 · 09-28
美因基因(06667)9月28日斥资65.6万港元回购9.16万股
美因基因(06667.HK)9月25日斥资65.88万港元回购9.42万股
智通财经 · 09-25
美因基因(06667.HK)9月25日斥资65.88万港元回购9.42万股
美因基因:9月25日回购9.42万股股份,耗资约65.88万港元
公告速递 · 09-25
美因基因:9月25日回购9.42万股股份,耗资约65.88万港元
加载更多
公司概况
公司名称:
美因基因
所属市场:
SEHK
上市日期:
--
主营业务:
美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.15,"timestamp":1791532767005,"preClose":7.175,"halted":0,"volume":190600,"delay":0,"changeRate":-0.003484320557491215,"floatShares":221000000,"shares":221000000,"eps":0.136851,"marketStatus":"休市中","change":-0.025,"latestTime":"10-09 15:59:27","open":7.25,"high":7.25,"low":7.12,"amount":1368113,"amplitude":0.018118,"askPrice":7.15,"askSize":400,"bidPrice":6.91,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.127,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":7,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.175,"dividendRate":0.024561,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":1.182676,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"1176183071","title":"美因基因10月9日回购15.2万股,耗资约109.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176183071","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176183071?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:36","pubTimestamp":1791538595,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月9日发布公告,当日于香港联交所场内回购普通股152,000股,占当日回购前公司已发行股份总数221,498,800股的约0.0686%。回购价格在每股港币7.14元至7.245元不等,合计支付1,092,531港元。公司回购授权于2026年5月21日获股东大会通过,可购回的股份总数为22,430,020股,截至目前已合计回购2,953,400股,约占该次购回授权通过当日已发行股份的1.3167%。本公告由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因10月9日回购15.2万股,耗资约109.25万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674830686","title":"美因基因(06667)10月9日斥资109.25万港元回购15.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674830686","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674830686?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:33","pubTimestamp":1791538408,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年10月9日斥资109.25万港元回购15.2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113571601","title":"美因基因:10月8日回购14.88万股,涉资约106.91万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113571601","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113571601?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:45","pubTimestamp":1791467146,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月8日发布翌日披露报表,公布当日于香港联交所场内回购股票的进展。本次回购数量为148,800股,约占2026年10月7日已发行股本221,647,600股的0.0671%,回购最高价为每股7.195港元,最低价为每股7.155港元,总代价为1,069,054港元。回购完成后,公司于10月8日的已发行股份总数变更为221,498,800股,库藏股数增至2,801,400股,合计股份总数仍为224,300,200股。公司确认,股份回购过程遵守了香港联交所证券上市规则及相关法规。本次公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因:10月8日回购14.88万股,涉资约106.91万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673016674","title":"美因基因(06667.HK)10月7日耗资116.94万港元回购16.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673016674","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673016674?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:17","pubTimestamp":1791382621,"startTime":"0","endTime":"0","summary":"格隆汇10月7日丨美因基因(06667.HK)公告,10月7日耗资116.94万港元回购16.14万股,每股回购价格7.205-7.295港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261007/32389392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182515588","title":"美因基因回购16.14万股股份,总额约116.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182515588","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182515588?lang=zh_cn&edition=full","pubTime":"2026-10-07 21:51","pubTimestamp":1791381119,"startTime":"0","endTime":"0","summary":"2026年10月7日,美因基因有限公司公告,当天于香港联交所场内回购普通股161,400股,占当日公司现有已发行股份总数的约0.0728%。回购价格介乎每股7.205港元至7.295港元,总计耗资约116.94万港元。公司此前于2026年5月21日获得回购授权,可回购股份总数为22,430,020股,截至目前已回购2,652,600股,约占授权通过时已发行股份总数的1.1826%。公司确认,本次回购符合香港联交所上市规则及相关法律法规的要求。本公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购16.14万股股份,总额约116.94万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143633528","title":"美因基因10月6日回购15.68万股,耗资约113.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143633528","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143633528?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:15","pubTimestamp":1791296141,"startTime":"0","endTime":"0","summary":"2026年10月6日,美因基因有限公司发布公告,公司于当日于香港联交所场内回购普通股共156,800股,占该次回购前公司已发行股份总数的约0.0706%,每股价格在7.03港元至7.295港元之间,合计耗资约113.81万港元。公告显示,本次股本变动完成后,公司于10月6日交易结束时的已发行股份总数为221,809,000股,另持有库存股份2,491,200股,总股份数为224,300,200股。此次回购基于公司于2026年5月21日通过的购回授权,公司可根据该授权回购的股份总数为22,430,020股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因10月6日回购15.68万股,耗资约113.81万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673544310","title":"美因基因(06667.HK)10月6日斥资113.81万港元回购15.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673544310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673544310?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:12","pubTimestamp":1791295976,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673054434","title":"美因基因(06667)10月6日斥资113.81万港元回购15.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054434","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673054434?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:12","pubTimestamp":1791295976,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年10月6日,该公司斥资113.81万港元回购15.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106207326","title":"美因基因更新2026年9月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1106207326","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106207326?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:50","pubTimestamp":1791201053,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月5日公布截至2026年9月30日的股份变动月报表。报告显示,公司法定注册股本维持在500,000,000股,面值为每股0.0001美元,总额50,000美元,未发生变更。其中,9月份通过回购安排减持已发行普通股1,409,000股,并相应增加相同数量的库藏股份。本次月报由公司董事姜晶代表签署。整体来看,公司本月股本总数保持在224,300,200股未变动,股本情况保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673348702","title":"美因基因(06667)10月5日斥资56.74万港元回购8.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673348702","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673348702?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:46","pubTimestamp":1791200766,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,该公司于2026年10月5日斥资56.74万港元回购8.06万股股份,每股回购价格为7.02-7.045港元,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135878846","title":"美因基因10月5日回购80,600股股份,耗资约56.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135878846","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135878846?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:45","pubTimestamp":1791200747,"startTime":"0","endTime":"0","summary":"美因基因于2026年10月5日发布翌日报表,披露公司当日于香港联交所场内回购普通股80,600股,占回购前公司已发行股本约0.0363%,每股购回价格介乎7.02港元至7.045港元,总金额约56.74万港元。回购后,公司已发行股本为221,965,800股,库藏股为2,334,400股,合计224,300,200股。本次回购依据公司于2026年5月21日通过的购回授权进行,授权购回股份总数为22,430,020股。公司表示,本次股份购回及相关事宜均已获得董事会正式授权,并符合法律及相关监管规定。本公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因10月5日回购80,600股股份,耗资约56.74万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714215","title":"美因基因:10月2日斥资54.4万港元回购7.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714215","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672714215?lang=zh_cn&edition=full","pubTime":"2026-10-02 20:39","pubTimestamp":1790944760,"startTime":"0","endTime":"0","summary":"南财智讯10月2日电,美因基因(06667.HK)发布翌日披露报表,10月2日,公司回购7.68万股,每股最高回购价为7.09港元,每股最低回购价为7港元,付出的总代价为54.4万港元。该批回购股份拟持作库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610023888387244.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610023888387244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188133631","title":"美因基因回购7.68万股股份,涉资约54.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188133631","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188133631?lang=zh_cn&edition=full","pubTime":"2026-10-02 20:35","pubTimestamp":1790944552,"startTime":"0","endTime":"0","summary":"美因基因有限公司在2026年10月2日公告称,当日于香港联交所场内回购普通股合计76,800股,占公司回购前已发行股本约0.0346%。每股回购价介乎港币7.00元至港币7.085元,合计耗资约54.40万港元。回购完成后,截至2026年10月2日,公司已发行股份总数为224,300,200股,其中库藏股为2,253,800股。本次股份回购依据公司于2026年5月21日通过的购回授权,授权可回购的股份总数达22,430,020股,截至目前已根据该授权于香港联交所及其他证券交易所共回购2,253,800股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购7.68万股股份,涉资约54.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121899813","title":"美因基因回购9.48万股股份,总额约68.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121899813","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121899813?lang=zh_cn&edition=full","pubTime":"2026-09-30 21:12","pubTimestamp":1790773966,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月30日发布公告,披露当日于香港联交所回购普通股94,800股,占公司现有已发行股份约0.0427%。本次回购价格区间介乎每股7.185港元至7.29港元,总涉资约68.25万港元。据悉,上述股份购回乃根据公司于2026年5月21日获通过的购回授权进行,授权下可回购的股份总数为22,430,020股,截至目前公司累计回购2,177,000股,占授权获通过当日已发行股份总额约0.9706%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购9.48万股股份,总额约68.25万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671073552","title":"美因基因(06667)9月30日斥资68.25万港元回购9.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671073552","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671073552?lang=zh_cn&edition=full","pubTime":"2026-09-30 21:10","pubTimestamp":1790773835,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年9月30日,该公司斥资68.25万港元回购9.48万股股份,每股回购价7.185-7.29港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111675618","title":"美因基因回购9.2万股股份,耗资约65.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111675618","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111675618?lang=zh_cn&edition=full","pubTime":"2026-09-29 20:21","pubTimestamp":1790684499,"startTime":"0","endTime":"0","summary":"美因基因于2026年9月29日发布公告,宣布在香港联交所场内回购92,000股普通股,约占此前已发行股本的0.0414%。每股回购价格介于每股港币6.96元至7.15元,合计耗资约65.62万港元。本次回购系基于公司于2026年5月21日通过的购回授权,授权总额对应22,430,020股。截至本次回购后,已回购股份数共计2,082,200股,占购回授权通过当日已发行股本约0.9283%。公司确认,本次回购行为已遵守香港联交所证券上市规则及相关法律法规。公告由公司董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购9.2万股股份,耗资约65.62万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147752664","title":"美因基因回购9.16万股股份,耗资约65.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147752664","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147752664?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:16","pubTimestamp":1790601396,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月28日发布公告,披露其在香港联交所场内回购股份。本次回购涉及91,600股普通股,约占此前公司已发行股本222,401,600股的0.0412%。回购价格区间为每股6.96港元至7.25港元,合计支付约65.60万港元。回购完成后,公司已发行股份变动为222,310,000股,库藏股数上升至1,990,200股,总已发行股份数维持224,300,200股。公司确认,本次回购行为已获董事会正式批准,并严格遵守香港联合交易所有限公司证券上市规则及其他适用法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购9.16万股股份,耗资约65.60万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670230206","title":"美因基因(06667)9月28日斥资65.6万港元回购9.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670230206","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670230206?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:14","pubTimestamp":1790601280,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年9月28日斥资65.6万港元回购9.16万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670599440","title":"美因基因(06667.HK)9月25日斥资65.88万港元回购9.42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670599440","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670599440?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:41","pubTimestamp":1790340100,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134191315","title":"美因基因:9月25日回购9.42万股股份,耗资约65.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134191315","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134191315?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:41","pubTimestamp":1790340092,"startTime":"0","endTime":"0","summary":"美因基因有限公司(股份代号:06667)于2026年9月25日公布翌日披露报表,披露公司当日通过香港联交所场内回购股份9.42万股,约占相关变动前已发行股份0.0423%。回购价格介乎每股6.99港元至6.995港元,总金额约65.88万港元。\n本次回购完成后,公司已发行股份由2.224958亿股减少至2.224016亿股,库存股份增加至189.86万股,公司总已发行股份数仍维持2.243002亿股。回购所涉授权于2026年5月21日获股东大会通过,可回购股份总数为2243.002万股。公司确认其已遵守香港联合交易所有限公司证券上市规则及相关法律法规的规定。\n本公告由公司董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因:9月25日回购9.42万股股份,耗资约65.88万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":-0.0035},{"period":"3month","weight":0.1051},{"period":"6month","weight":-0.002},{"period":"1year","weight":0.0174},{"period":"ytd","weight":0.0174}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":-0.0421},{"period":"3month","weight":0.0015},{"period":"6month","weight":-0.065},{"period":"1year","weight":-0.095},{"period":"ytd","weight":-0.0554}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.5,"avgChangeRate":0.008854},{"month":8,"riseRate":0.25,"avgChangeRate":-0.060544},{"month":9,"riseRate":0,"avgChangeRate":-0.127252},{"month":10,"riseRate":0.25,"avgChangeRate":-0.053985},{"month":11,"riseRate":0.333333,"avgChangeRate":0.114508},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}